Regulation And Legal
iSERA Lifesciences Shareholders Approve Disclosure Amendments
iSERA Lifesciences re-opened e-voting for two disclosure amendments to its preferential issue explanatory statement, as required by BSE.
Shareholders unanimously approved both resolutions: correcting
